ARCHIVES

Slow Accruing Trials Should Be Removed From High Priority Program, Broder Says

This article is from The Cancer Letter archive.

Vol. 18 No. 38 | October 2, 1992

Download PDF Visit The Full Archive

Related Articles

FY2000 Appropriations: NIH Gets $17.9 Billion, A 15% Increase, In Final Budget Agreement; $3 billion to Be Delayed

November 26, 1999

Evidence Too Weak to Link Agent Orange, Cancer, IOM Says

March 22, 2002

FDA Urges Lower Target for ESA Use; Market Could Drop By More Than Half.

March 16, 2007

In Brief: Simone Is AACI President-Elect; McGill, ICRC New Members; Engstrom ECOG Prevention Head

July 12, 1991

Prostate Cancer Council Calls For Long-Term Screening Research

September 10, 1993

Patients “Raise A Voice” For Provenge Approval.

April 27, 2007